August 27, 2019 09:03 AM EDT

For sale: Boston Children’s team touts a new CRISPR delivery system for triple-negative breast cancer — plus — after testing it in mice and cells

A team of investigators at Boston Children’s has developed a new delivery vehicle for CRISPR that amps up its ability to eliminate a key target …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

For sale: Boston Chil­dren’s team touts a new CRISPR de­liv­ery sys­tem for triple-neg­a­tive breast can­cer — plus — af­ter test­ing it in mice and cells